ACT Genomics closes $12.5mm Series B round
ACT Genomics Co. Ltd. (molecular diagnostics and precision cancer care) raised $12.5mm through its Series B round from co-leads...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2016.
ACT Genomics closes $12.5mm Series B round
ACT Genomics Co. Ltd. (molecular diagnostics and precision cancer care) raised $12.5mm through its Series B round from co-leads...